Two poster presentations to feature novel data from the Phase 1/2 SIDNEY trial of EO2463 in indolent Non-Hodgkin Lymphoma (iNHL), highlighting ...

In this on-demand webinar series, CURE partnered with City of Hope to discuss effective communication when making treatment ...

It’s common to experience a range of emotions when your husband, wife, or partner is diagnosed with cancer. You may feel like they are pushing you away if they don’t seem accepting of your efforts.

People who both smoke cigarettes and use electronic cigarettes (e-cigarettes, e-cigs, or vapes) are 4 times more likely to develop lung cancer than people who only smoke cigarettes, new research finds ...

Published positive Phase 2 trial results of onvansertib in combination with FOLFIRI and bev in second-line KRAS mutant mCRC in the ...

Though the effect on physician reimbursement will vary, ASCO estimates a 4% decrease for medical oncology, a 3.25% decrease for radiation oncology and a 3.6% decrease for gynecologic oncology in 2025.

FCS is a recipient of the national Clinical Trials Participation Award presented by the American Society of Clinical Oncology (ASCO). FCS physicians, trained in prestigious medical schools and ...

Katherine Van Loon, MD, MPH, has been appointed as the next editor-in-chief of JCO Global Oncology (JCO GO), an American Society of Clinical Oncology (ASCO) journal.

Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that board-certified medical oncologist and hematologist Gustavo Westin, MD has joined its team of cancer experts in ...

Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a ...